Comparison of four serological methods and two reverse transcription-PCR assays for diagnosis and surveillance of Zika virus infection

Journal of Clinical Microbiology

Volumn 56, Issue 3, 2018, Pages

  Balmaseda, Angel ^a,b   Zambrana, José Victor ^b   Collado, Damaris ^b   García, Nadezna ^a,b   Saborío, Saira ^a,b   Elizondo, Douglas ^b   Mercado, Juan Carlos ^a,b   Gonzalez, Karla ^a,b   Cerpas, Cristhiam ^a,b   Nuñez, Andrea ^a,b   Corti, Davide ^c   Waggoner, Jesse J ^d   Kuan, Guillermina ^a,b   Burger Calderon, Raquel ^b,e   Harris, Eva ^b,e  

^a Ministry of Health   (Nicaragua)

^b Sustainable Sciences Institute   (Nicaragua)

^c Subsidiary of Vir Biotechnology Inc ^*  (Switzerland)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dengue virus; Diagnosis; ELISA; RT PCR; Serological assay; Surveillance; Zika virus

Indexed keywords

IMMUNOGLOBULIN M; NONSTRUCTURAL PROTEIN 1; VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ARTICLE; CHIKUNGUNYA VIRUS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CONVALESCENCE; DENGUE; DENGUE VIRUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NICARAGUA; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROLOGY; ZIKA FEVER; COMPARATIVE STUDY; CROSS REACTION; EPIDEMIOLOGICAL MONITORING; EVALUATION STUDY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; STANDARDS; ZIKA VIRUS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS REACTIONS; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; NICARAGUA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85042609440     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01785-17     Document Type: Article

References (37)

1. do Rosário MS, de Jesus PA, Vasilakis N, Farias DS, Novaes MA, Rodrigues SG, Martins LC, Vasconcelos PF, Ko AI, Alcântara LC, de Siqueira IC. 2016. Guillain-Barre syndrome after Zika virus infection in Brazil. Am J Trop Med Hyg 95:1157–1160. https://doi.org/10.4269/ajtmh.16-0306.
2. Mlakar J, Korva M, Tul N, Popovic M, Poljsak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodusek V, Vizjak A, Pizem J, Petrovec M, Avsic Zupanc T. 2016. Zika virus associated with microcephaly. N Engl J Med 374:951–958. https://doi.org/10.1056/NEJMoa1600651.
3. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. 2016. Zika virus and birth defects—reviewing the evidence for causality. N Engl J Med 374:1981–1987. https://doi.org/10.1056/NEJMsr1604338.
4. Siu R, Bukhari W, Todd A, Gunn W, Huang QS, Timmings P. 2016. Acute Zika infection with concurrent onset of Guillain-Barre syndrome. Neurology 87:1623–1624. https://doi.org/10.1212/WNL.0000000000003038.
5. Cicuto Ferreira Rocha NA, de Campos AC, Cicuto Ferreira Rocha F, Pereira Dos Santos Silva F. 2017. Microcephaly and Zika virus: neuroradiological aspects, clinical findings and a proposed framework for early evaluation of child development. Infant Behav Dev 49:70 – 82. https://doi.org/10.1016/j.infbeh.2017.07.002.
6. Ventura CV, Maia M, Bravo-Filho V, Gois AL, Belfort R, Jr. 2016. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet 387:228. https://doi.org/10.1016/S0140-6736(16)00006-4.
7. Ventura CV, Maia M, Ventura BV, Linden VV, Araujo EB, Ramos RC, Rocha MA, Carvalho MD, Belfort R, Jr, Ventura LO. 2016. Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection. Arq Bras Oftalmol 79:1–3. https://doi.org/10.5935/0004-2749.20160002.
8. Aziz H, Zia A, Anwer A, Aziz M, Fatima S, Faheem M. 2017. Zika virus: global health challenge, threat and current situation. J Med Virol 89: 943–951. https://doi.org/10.1002/jmv.24731.
9. Faria NR, Azevedo R, Kraemer MUG, Souza R, Cunha MS, Hill SC, Theze J, Bonsall MB, Bowden TA, Rissanen I, Rocco IM, Nogueira JS, Maeda AY, Vasami F, Macedo FLL, Suzuki A, Rodrigues SG, Cruz ACR, Nunes BT, Medeiros DBA, Rodrigues DSG, Queiroz ALN, da Silva EVP, Henriques DF, da Rosa EST, de Oliveira CS, Martins LC, Vasconcelos HB, Casseb LMN, Simith DB, Messina JP, Abade L, Lourenco J, Alcantara LCJ, de Lima MM, Giovanetti M, Hay SI, de Oliveira RS, Lemos PDS, de Oliveira LF, de Lima CPS, da Silva SP, de Vasconcelos JM, Franco L, Cardoso JF, Vianez-Junior J, Mir D, Bello G, Delatorre E, Khan K, et al. 2016. Zika virus in the Americas: early epidemiological and genetic findings. Science 352: 345–349. https://doi.org/10.1126/science.aaf5036.
10. Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, Sakuntabhai A, Cao-Lormeau VM, Malasit P, Rey FA, Mongkolsapaya J, Screaton GR. 2016. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat Immunol 17:1102–1108. https://doi.org/10.1038/ni.3515.
11. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR. 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:1232–1239. https://doi.org/10.3201/eid1408.080287.
12. Landry ML, St George K. 2017. Laboratory diagnosis of Zika virus infection. Arch Pathol Lab Med 141:60–67. https://doi.org/10.5858/arpa.2016-0406-SA.
13. Raboni SM, Bonfim C, Almeida BM, Zanluca C, Koishi AC, Rodrigues P, Kay CK, Ribeiro LL, Scola RH, Duarte Dos Santos CN. 2017. Flavivirus cross-reactivity in serological tests and Guillain-Barre syndrome in a hematopoietic stem cell transplant patient: a case report. Transpl Infect Dis 19:e12700. https://doi.org/10.1111/tid.12700.
14. Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D. 2016. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353:823–826. https://doi.org/10.1126/science.aaf8505.
15. CDC. 2017. Trioplex real-time RT-PCR assay; instructions for use. CDC, Atlanta, GA.
16. Waggoner JJ, Gresh L, Mohamed-Hadley A, Ballesteros G, Davila MJ, Tellez Y, Sahoo MK, Balmaseda A, Harris E, Pinsky BA. 2016. Single-reaction multiplex reverse transcription PCR for detection of Zika, chikungunya, and dengue viruses. Emerg Infect Dis 22:1295–1297. https://doi.org/10.3201/eid2207.160326.
17. Brasil P, Pereira JP, Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, Rabello RS, Valderramos SG, Halai UA, Salles TS, Zin AA, Horovitz D, Daltro P, Boechat M, Raja Gabaglia C, Carvalho de Sequeira P, Pilotto JH, Medialdea-Carrera R, Cotrim da Cunha D, Abreu de Carvalho LM, Pone M, Machado Siqueira A, Calvet GA, Rodrigues Baiao AE, Neves ES, Nassar de Carvalho PR, Hasue RH, Marschik PB, Einspieler C, Janzen C, Cherry JD, Bispo de Filippis AM, Nielsen-Saines K. 2016. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 375:2321–2334. https://doi.org/10.1056/NEJMoa1602412.
18. Balmaseda A, Saborio S, Tellez Y, Mercado JC, Perez L, Hammond SN, Rocha C, Kuan G, Harris E. 2008. Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J Clin Virol 43:287–291. https://doi.org/10.1016/j.jcv.2008.07.016.
19. L’Huillier AG, Hamid-Allie A, Kristjanson E, Papageorgiou L, Hung S, Wong CF, Stein DR, Olsha R, Goneau LW, Dimitrova K, Drebot M, Safronetz D, Gubbay JB. 2017. Evaluation of Euroimmun anti-Zika virus IgM and IgG enzyme-linked immunosorbent assays for Zika virus serologic testing. J Clin Microbiol 55:2462–2471. https://doi.org/10.1128/JCM.00442-17.
20. Kuan G, Gordon A, Aviles W, Ortega O, Hammond SN, Elizondo D, Nunez A, Coloma J, Balmaseda A, Harris E. 2009. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170:120–129. https://doi.org/10.1093/aje/kwp092.
21. Balmaseda A, Gordon A, Gresh L, Ojeda S, Saborio S, Tellez Y, Sanchez N, Kuan G, Harris E. 2016. Clinical attack rate of Chikungunya in a cohort of Nicaraguan children. Am J Trop Med Hyg 94:397–399. https://doi.org/10.4269/ajtmh.15-0413.
22. Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D. 2017. Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci U S A 114:8384–8389. https://doi.org/10.1073/pnas.1704984114.
23. BEI Resources. 2016. NIAID Zika virus (ZIKV) MAC-ELISA assay sheet. BEI Resources, Manassas, VA.
24. Waggoner JJ, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalez K, Ballesteros G, Balmaseda A, Karunaratne K, Harris E, Pinsky BA. 2013. Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J Clin Microbiol 51:2172–2181. https://doi.org/10.1128/JCM.00548-13.
25. Waggoner JJ, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalez K, Ballesteros G, Guo FP, Balmaseda A, Karunaratne K, Harris E, Pinsky BA. 2013. Comparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping. J Clin Microbiol 51:3418–3420. https://doi.org/10.1128/JCM.01359-13.
26. Galo SS, González K, Téllez Y, García N, Pérez L, Gresh L, Harris E, Balmaseda Á. 2017. Development of in-house serological methods for diagnosis and suveillance of chikungunya. Rev Panam Salud Publica 41:e56.
27. Balmaseda A, Guzman MG, Hammond S, Robleto G, Flores C, Tellez Y, Videa E, Saborio S, Perez L, Sandoval E, Rodriguez Y, Harris E. 2003. Diagnosis of dengue virus infection by detection of specific immuno-globulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol 10:317–322.
28. Clarke DH, Casals J. 1958. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 7:561–573. https://doi.org/10.4269/ajtmh.1958.7.561.
29. Reed LJ, Muench H. 1938. A simple method of estimating 50% endpoints. Am J Epidemiol 27:493–497. https://doi.org/10.1093/oxfordjournals.aje.a118408.
30. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, Saborio SI, Mercado JC, Perez L, Videa E, Almanza E, Kuan G, Reyes M, Saenz L, Amador JJ, Harris E. 2006. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 11:935–942. https://doi.org/10.1111/j.1365-3156.2006.01641.x.
31. Waggoner J, Heath CJ, Ndenga B, Mutuku F, Sahoo MK, Mohamed-Hadley A, Vulule J, Mukoko D, Desiree LaBeaud A, Pinsky BA. 2017. Development of a real-time reverse transcription polymerase chain reaction for O’nyong-nyong virus and evaluation with clinical and mosquito specimens from Kenya. Am J Trop Med Hyg 97:121–124. https://doi.org/10.4269/ajtmh.17-0027.
32. Fourcade C, Mansuy JM, Dutertre M, Delpech M, Marchou B, Delobel P, Izopet J, Martin-Blondel G. 2016. Viral load kinetics of Zika virus in plasma, urine and saliva in a couple returning from Martinique, French West Indies. J Clin Virol 82:1–4. https://doi.org/10.1016/j.jcv.2016.06.011.
33. Pessoa R, Patriota JV, de Souza MDL, Abd El Wahed A, Sanabani SS. 2016. Detection of Zika virus in Brazilian patients during the first five days of infection-urine versus plasma. Euro Surveill 21(30):pii30302. http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2016.21.30.30302.
34. Safronetz D, Sloan A, Stein DR, Mendoza E, Barairo N, Ranadheera C, Scharikow L, Holloway K, Robinson A, Traykova-Andonova M, Makowski K, Dimitrova K, Giles E, Hiebert J, Mogk R, Beddome S, Drebot M. 2017. Evaluation of 5 commercially available Zika virus immunoassays. Emerg Infect Dis 23:1577–1580. https://doi.org/10.3201/eid2309.162043.
35. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, Saborio S, Hammond SN, Nunez A, Aviles W, Henn MR, Holmes EC, Gordon A, Coloma J, Kuan G, Harris E. 2010. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 201:5–14. https://doi.org/10.1086/648592.
36. Gordon A, Kuan G, Mercado JC, Gresh L, Aviles W, Balmaseda A, Harris E. 2013. The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004–2010. PLoS Negl Trop Dis 7:e2462. https://doi.org/10.1371/journal.pntd.0002462.
37. Montoya M, Gresh L, Mercado JC, Williams KL, Vargas MJ, Gutierrez G, Kuan G, Gordon A, Balmaseda A, Harris E. 2013. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis 7:e2357. https://doi.org/10.1371/journal.pntd.0002357.